Select a Region North America

Commercialize Cell & Gene Therapies

Cell and Gene Therapy Excellence

Leading the Wayin Cell and Gene Therapy Commercialization

There is no question about the incredible clinical impact cell and gene therapies (CGTs) can have on the lives of patients. However, this impact is the result of innovation that does not equate to a simple, straightforward commercialization process. The commercialization and management requirements of these treatments are just as complex as their innovative science.

Commercialization of CGTs is significantly more challenging compared to traditional biopharma products.​ Their inherent complexity impacts distribution, access, affordability and patient support.

CGTs hold great life-saving and therapeutic advancement potential, but their complexity requires a careful approach–starting with engaging and educating patient communities earlier.

Leading the Way in Cell and Gene Therapy Commercialization

Leveraging CGT Expertise from Product Development Through Launch

As the industry focuses more on specialty therapies, it is imperative that manufacturers move to a patient-centered care model that delivers value enabled by innovative technologies and measured by actionable data. EVERSANA incorporates the patient perspective throughout the lifecycle of CGTs. We partner with innovators to think differently about their commercialization strategies, channel distribution, patient support and capability investments for market readiness.  

We leverage our CGT expertise to bring together strategy, patient recruitment for clinical trials, HCPs and patient engagement across the patient journey, and warehousing and logistics to support the complexities associated with cell and gene therapies.

We incorporate the patient perspective throughout the lifecycle of cell and gene therapies.

  • Pre-Clinical

    Infuse the patient voice into trial programs

    • Meaningful clinical trial endpoints
    • Clinical trial support and resources
    • Form ongoing partnerships
  • Clinical/Pre-Launch

    Provide education and resources to support trials and community

    • Disease education
    • FDA Advisory Committee meetings
    • Patient advocacy group partnerships
  • Commercial

    Identify how patient needs intersect with brand objectives

    • Insight-driven marketing materials
    • Co-created resources and support
    • Patient programs, such as approved Risk Evaluation and Mitigation Strategy (REMS) programs

Contact us to learn more about our Cell & Gene Therapy Solutions.

Featured Content

Navigating Routes to Commercial Excellence in Cell and Gene Therapy

“Navigating Routes to Commercial Success in Cell and Gene Therapy” discusses the unique challenges faced by companies developing and commercializing cell and gene therapies (CGTs). The paper highlights the significant potential of CGTs in treating previously incurable diseases and the need for a tailored approach to commercialization given the complexity of these therapies, high development costs, and regulatory hurdles. It provides an overview of the current market landscape and emerging trends in CGT development and commercialization, including the importance of real-world evidence, patient engagement, and pricing and reimbursement strategies. The paper also outlines best practices for successfully navigating the commercialization journey, including the importance of a cross-functional approach, strong data […]

THINK BEYOND THE THERAPY: Demystifying the Complexities of Cell and Gene Therapy Commercialization

While much attention has been given to the novel science behind cell and gene therapies, ultimately the success of every precision medicine starts and ends with the patient. Whether coordinating a cell or gene therapy clinical trial or product launch, even the best-planned efforts can be derailed without a clear strategy for facilitating access to the therapy and supporting patients through the treatment journey. This is true for almost every specialty product, but it is especially important for cell and gene therapies, given the high cost and complexity of administering these innovative new therapies. On the surface, the commercialization process for cell and gene therapies may seem simple. However, many […]

EVERSANA’s Expertise in Cell and Gene Therapies Makes Commercialization Predictable



    Built for the pharmaceutical and biotechnology industries, our global experts help industry executives address their most pressing business challenges.



    This new multi stakeholder era of healthcare demands a strategic and creative partner who’s adept at making connections among patients, providers, and payers.

  • Global Channel & 3PL

    Global Channel & 3PL

    Rely on us to manage all unique handling and individualized transportation needs, including urgent access programs for critical patient needs.



Contact us to learn more about our CGTs solutions.